Perkins carefully assess each patient to ensure they are a good candidate for Tirzepatide or Semaglutide injections
Eligible participants were adults with type 2 diabetes irrespective of background glucose-lowering treatment
Injectable bioavailability: Highest
Erecinska, M., Nelson, D., Daikhin, Y
To date, the structures of active state GLP-1R:G s complexes bound to either the native GLP-1 peptide or a G protein biased agonist, exendin-P5 (ExP5) have been determined using cryo-EM (Liang et al., 2018b
Comparing GLP-1 Agonists with Other Weight Loss Medications GLP-1 agonists have the advantage of targeting both appetite regulation and glucose metabolism, making them especially effective for individuals with obesity and type 2 diabetes